Comunicados de prensa

Merkley, Risch Lead Bipartisan Push to Strengthen the United States’ Commitment to Tibet

Washington, D.C. – Today, U.S. Senator Jeff Merkley (D-OR) partnered with Jim Risch (R-ID), Chairman of the Senate Foreign Relations Committee, to lead the introduction of the Assuring the Future of Tibet Act. The bipartisan bill would strengthen U.S. engagement with the Central Tibetan Administration (CTA), the democratically elected representative of

Merkley Statement on Russia Sanctions to Bolster Ukraine’s Fight for Democracy

WASHINGTON, D.C. – Today, Oregon’s U.S. Senator Jeff Merkley – a senior member of the Senate Foreign Relations Committee – issued the following statement after the Senate passed bipartisan legislation to crack down on Russia’s ability to fund its war in Ukraine: “The United States must stand with democratic republics

Merkley: TSA’s Facial Recognition Regime Continues to Lack Proper Congressional Oversight

Washington, D.C. – Oregon’s U.S. Senator Jeff Merkley today issued the following statement after the Senate voted last night to pass the Federal Aviation Administration (FAA) Reauthorization Act without a vote on his amendment to address the Transportation Security Administration’s (TSA) use of facial recognition technology: “Facial surveillance creates the

Merkley Announces Town Halls in Eastern Oregon

Washington, D.C. – Oregon’s U.S. Senator Jeff Merkley announced today he will be holding nine in-person town halls for Eastern Oregon counties in May: Malheur, Harney, and Grant counties on Friday, May 17; Baker, Union, and Wallowa counties on Saturday, May 18; and Umatilla, Morrow, and Gilliam counties on Sunday, May

Warren, Sanders, Merkley Slam Chamber of Commerce for Opposition to Biden Administration’s Proposal to Boost Competition, Lower Drug Prices

“These efforts are a mistake, and are not consistent with the Chamber’s stated goal of ‘expand(ing) access to and improv(ing) the affordability of high-quality health care services for all Americans.’ If successful, they will undermine the Biden Administration’s effort to reduce drug prices and insurance premiums, hurting consumers and small and large businesses.” 

es_MXSpanish